Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
BLOG
EVENT CALENDAR
COLUMNS
WHITE PAPERS
THE MAGAZINE
  Pharmaceutical Technology Europe E-Alert
 
27 September 2010
IN THIS ISSUE
• Elan in the clear
 • FDA warns BMS
• Confidentiality arrangements
 • FDA generic fees


Elan management cleared of wrongdoing
An external review has cleared Elan Corp (Ireland) of any wrongdoing following “a number of matters” brought to the Board’s attention by some directors concerning corporate governance practices. More...
 
FDA warning to Bristol-Myers Squibb
The FDA has issued a Warning Letter to Bristol-Myers Squibb that describes violations of cGMP that the agency observed at the company’s Manati, Puerto Rico manufacturing facility. More...
 
EMA and FDA extend confidentiality arrangements indefinitely
The EMA and the FDA have extended their confidentiality arrangements for human and veterinary medicinal products following the “positive experience” gained since the initial arrangements were signed in 2003. More...
 
FDA calls for generic drug user fees
With the FDA approval process for generic drugs facing many challenges, the FDA Commissioner has spoken about the possibility of enacting user fees for the generic-drug sector to boost FDA resources. More...
 
Johnson & Johnson in negotiations to buy Crucell
Johnson & Johnson is in “advanced negotiations” for a potential public offer for the Dutch biopharmaceutical company Crucell, although a formal bid has not yet been made. More...
 
Join us on Twitter
For regular industry news updates and headlines follow us on Twitter. More...

Latest blog posts
J&J seeks to boost vaccine capabilities
FDA panel votes ‘No’ on Arenas’s obesity drug
Genzyme steals headlines again
More blog posts

Latest columns
Behind the scenes of pharma mergers and acquisitions
Small-molecule synthesis
R&D mash-ups
More columns

Upcoming events
Bio-IT World Expo Europe (5–7 October | Germany)
CPhI Worldwide 2010 (5–7 October | France)
2010 PDA Europe Conference on Pharmaceutical Cold Chain Management (7–8 October | Germany)
More events


Product Profiles
Oxoid
BioProcess Containers
Oxoid Cold filterable Tryptone Soya Broth that just plugs into processing lines for your media fills trials. Made with WFI quality water, each batch comes with quality certification. No media preparation, no QC, just less stressful media fills to get your production lines running as efficiently as possible.

Read more...

Oxoid
Genetic Identification and Characterization in less than 8 Hours
The DuPont Qualicon RiboPrinter® microbial characterization system provides the speed, accuracy and resolution needed to identify bacteria and compare them at the strain level characterization, all in less than 8 hours. This automated system is available in Europe, Canada and Australia alongside Oxoid products.

Read more...

Agilent
One for all with Agilent Multi-Vendor Services. Now you can get comprehensive repair, maintenance and compliance support for all major LC, GC and MS models in your lab regardless of manufacturer.

Read more...

Event Profile
Bio-Europe Winter
November 15-17 2010
Munich, Germany
The 16th annual BIO-Europe event will be the largest biotechnology partnering conference held in Europe. Over 2,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships.

Read more...

Wockhardt

Thanks to expert staff, Wockhardt has become a leading global Pharmaceutical Contract Manufacturer. From development to high-volume commercial manufacture, we utilise more than 25 years of contract manufacturing experience to ensure your product is professionally managed all the way to market.

Read more...


 


Survey
Should the FDA have mandatory recall authority and the power to halt drug production?
    • Industry/trade publications
    • Mainstream news outlets
    • FDA alerts
    • Word of mouth
    • Other

This week we would like to know...

What is the most important feature of pharma secondary packaging?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom